Back to the list
Congress: ECR24
Poster Number: C-24315
Type: EPOS Radiologist (educational)
DOI: 10.26044/ecr2024/C-24315
Authorblock: F. Abubacker Sulaiman, G. Manikandan; Chennai, TN/IN
Disclosures:
Farook Abubacker Sulaiman: Nothing to disclose
Gajendran Manikandan: Nothing to disclose
Keywords: Abdomen, Contrast agents, Genital / Reproductive system male, MR, Diagnostic procedure, Molecular imaging, Monoclonal antibodies
References
  1. Silva F, Cabral Campello MP, Paulo A. Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer. Materials [Internet]. 2021 Jan 1;14(1):4. Available from: https://www.mdpi.com/1996-1944/14/1/4/htm
  2. Purysko AS, Ronaldo Hueb Baroni, Giganti F, Costa DP, Raphaële Renard-Penna, Chan Yun Kim, et al. PI-RADS Version 2.1: A Critical Review, From the AJR Special Series on Radiology Reporting and Data Systems. Andrei S Purysko. 2021 Jan 1;216(1):20–32.
  3. Barani M, Sabir F, Rahdar A, Arshad R, Kyzas GZ. Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates. Nanomaterials. 2020 Aug 28;10(9):1696.
  4. Purysko AS, Rosenkrantz AB, Turkbey IB, Macura KJ. RadioGraphics Update: PI-RADS Version 2.1—A Pictorial Update. RadioGraphics. 2020 Nov;40(7):E33–7.
  5. Adekiya TA, Moore M, Thomas M, Lake G, Hudson T, Adesina SK. Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer. Pharmaceutics [Internet]. 2024 Jan 16 [cited 2024 Feb 3];16(1):114. Available from: https://pubmed.ncbi.nlm.nih.gov/38258124/
  6. Yasin D, Sami N, Afzal B, Husain S, Naaz H, Ahmad N, et al. Prospects in the use of gold nanoparticles as cancer theranostics and targeted drug delivery agents. Applied Nanoscience. 2022 Nov 14;13(2).
  7. Raheem MA, Rahim MA, Gul I, Zhong X, Xiao C, Zhang H, et al. Advances in nanoparticles-based approaches in cancer theranostics. OpenNano [Internet]. 2023 Jul 1 [cited 2024 Feb 3];12(100152):100152. Available from: https://www.sciencedirect.com/science/article/pii/S2352952023000312
  8. Farzanegan Z, Tahmasbi M. Evaluating the Applications and Effectiveness of Magnetic nanoparticle-based Hyperthermia for Cancer treatment: a Systematic Review. Applied Radiation and Isotopes [Internet]. 2023 Aug 1;198(110873):110873. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0969804323002269?scrlybrkr=045f85dd
  9. Wabler M, Zhu W, Hedayati M, Attaluri A, Zhou H, Mihalic J, et al. Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content. International Journal of Hyperthermia. 2014 Apr 28;30(3):192–200.
  10. Purysko AS. Invited Commentary: Prostate Cancer Diagnosis—Challenges and Opportunities for Artificial Intelligence. RadioGraphics. 2021 Oct;41(6):E177–8.
  11. Ren X, Nur Salihin Yusoff M, Hartini Mohd Taib N, Zhang L, Wang K. 68Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in the detection of primary prostate cancer: A systematic review and head-to-head comparative meta-analysis. European Journal of Radiology [Internet]. 2024 Jan 1 [cited 2024 Feb 3];170(111274):111274. Available from: https://www.sciencedirect.com/science/article/pii/S0720048X23005880#:~:text=The%20results%20showed%20that%20the
  12. Tătaru OS, Vartolomei MD, Rassweiler JJ, Virgil O, Lucarelli G, Porpiglia F, et al. Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives. Diagnostics [Internet]. 2021 Feb 20;11(2):354. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924061/pdf/diagnostics-11-00354.pdf
  13. Gao X, Li L, Cai X, Huang Q, Xiao J, Cheng Y. Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges. Biomaterials [Internet]. 2021 Jan 1 [cited 2024 Feb 3];265(120404):120404. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0142961220306505?via%3Dihub
  14. Jin C, Wang K, Oppong-Gyebi A, Hu J. Application of Nanotechnology in Cancer Diagnosis and Therapy - a Mini-Review. International Journal of Medical Sciences [Internet]. 2020 Oct 18;17(18):2964–73. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646098/
  15. Han X, Xu K, Taratula O, Farsad K. Applications of Nanoparticles in Biomedical Imaging. Nanoscale. 2019;11(3):799–819.
  16. Wahajuddin, Arora. Superparamagnetic Iron Oxide nanoparticles: Magnetic Nanoplatforms as Drug Carriers. International Journal of Nanomedicine. 2012 Jul;7(2):3445.
  17. Pranav, Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. Journal of Advanced Research [Internet]. 2023 Sep 1 [cited 2023 Nov 10];51(2):197–217. Available from: https://www.sciencedirect.com/science/article/pii/S2090123222002508#:~:text=Functionalizing%20nanomaterials%20with%20different%20biomolecules
  18. Luo D, Wang X, Burda C, Basilion JP. Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis. Cancers. 2021 Apr 11;13(8):1825.
  19. Debnath S, Zhou N, McLaughlin M, Rice S, Pillai AK, Hao G, et al. PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective. International Journal of Molecular Sciences [Internet]. 2022 Jan 1 [cited 2023 Aug 29];23(3):1158. Available from: https://www.mdpi.com/1422-0067/23/3/1158?type=check_update&version=2
  20. Mosleh-Shirazi S, Abbasi M, Moaddeli MR, Vaez A, Shafiee M, Kasaee SR, et al. Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview. Nanotheranostics [Internet]. 2022;6(4):400–23. Available from: https://pubmed.ncbi.nlm.nih.gov/36051855/
  21. Kemp JA, Kwon YJ. Cancer nanotechnology: Current Status and Perspectives. Nano Convergence. 2021 Nov 2;8(1).
  22. Wang Y, Wang J, Yang L, Wei W, Sun B, Na K, et al. Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy. Nanomedicine: Nanotechnology, Biology and Medicine. 2019 Oct;21(12):102066.
  23. Saha A, Hosseinzadeh M, Huisman H. End-to-end Prostate Cancer Detection in bpMRI via 3D CNNs: Effects of Attention mechanisms, Clinical Priori and Decoupled False Positive Reduction. Medical Image Analysis. 2021 Oct;73(1):102155.
  24. Ortiz-Castillo JE, Gallo-Villanueva RC, Madou MJ, Perez-Gonzalez VH. Anisotropic Gold nanoparticles: a Survey of Recent Synthetic Methodologies. Coordination Chemistry Reviews. 2020 Dec;425(1):213489.
GALLERY